Key Points
- Insider buying: CVS Group director Scott Morrison purchased 987 shares on May 27 at GBX 1,270 each, for a total of £12,534.90.
- Stock and financial snapshot: The shares opened at GBX 1,241, with a market value of about £870.65 million and a 12-month range of GBX 1,062 to GBX 1,648. The company also carries a high debt-to-equity ratio of 121.52.
- Analyst sentiment remains positive: Berenberg and RBC reiterated buy/outperform ratings with price targets of GBX 2,000 and GBX 1,900, respectively. Overall, analysts rate CVS Group as a Moderate Buy with an average target of GBX 1,724.
CVS Group plc (LON:CVSG - Get Free Report) insider Scott Morrison bought 987 shares of the business's stock in a transaction that occurred on Wednesday, May 27th. The shares were acquired at an average price of GBX 1,270 per share, with a total value of £12,534.90.
CVS Group Stock Performance
LON:CVSG opened at GBX 1,241 on Friday. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 121.52. CVS Group plc has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648. The stock has a 50-day moving average price of GBX 1,173.53 and a 200 day moving average price of GBX 1,244.81. The stock has a market capitalization of £870.65 million, a P/E ratio of 18.01, a P/E/G ratio of 1.77 and a beta of 1.02.
CVS Group (LON:CVSG - Get Free Report) last released its earnings results on Thursday, February 26th. The company reported GBX 40.20 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.35% and a net margin of 2.31%. Equities research analysts forecast that CVS Group plc will post 93.9393939 EPS for the current fiscal year.
CVS Group announced that its board has initiated a stock repurchase program on Tuesday, May 26th that allows the company to buyback 0 shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company's management believes its stock is undervalued.
Analysts Set New Price Targets
CVSG has been the subject of several research analyst reports. Berenberg Bank reiterated a "buy" rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Tuesday. Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 1,900 target price on shares of CVS Group in a research report on Thursday, March 5th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of GBX 1,724.
Check Out Our Latest Stock Report on CVS Group
About CVS Group
(
Get Free Report)
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
